Outlook Therapeutics (OTLK) Assets Average: 2016-2020
Historic Assets Average for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $21.7 million.
- Outlook Therapeutics' Assets Average fell 13.84% to $21.7 million in Q2 2020 from the same period last year, while for Jun 2020 it was $21.7 million, marking a year-over-year decrease of 13.84%. This contributed to the annual value of $19.7 million for FY2019, which is 8.37% down from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Assets Average is $21.7 million, which was up 84.01% from $11.8 million recorded in Q1 2020.
- Outlook Therapeutics' Assets Average's 5-year high stood at $30.9 million during Q2 2018, with a 5-year trough of $11.8 million in Q1 2020.
- Over the past 3 years, Outlook Therapeutics' median Assets Average value was $23.4 million (recorded in 2019), while the average stood at $22.5 million.
- Per our database at Business Quant, Outlook Therapeutics' Assets Average soared by 78.89% in 2018 and then tumbled by 40.26% in 2019.
- Quarterly analysis of 5 years shows Outlook Therapeutics' Assets Average stood at $22.9 million in 2016, then increased by 15.61% to $26.5 million in 2017, then dropped by 22.67% to $20.5 million in 2018, then slumped by 32.77% to $13.8 million in 2019, then declined by 13.84% to $21.7 million in 2020.
- Its Assets Average stands at $21.7 million for Q2 2020, versus $11.8 million for Q1 2020 and $13.8 million for Q4 2019.